For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and the formulated version represents a significant advancement . These innovative therapies protect the transthyretin protein, halting its destructive build-up and reducing the severity of the disease . People are now